↓ Skip to main content

Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models

Overview of attention for article published in Frontiers in oncology, June 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models
Published in
Frontiers in oncology, June 2023
DOI 10.3389/fonc.2023.1200897
Pubmed ID
Authors

Meike Kaehler, Pia Osteresch, Axel Künstner, Stella Juliane Vieth, Daniela Esser, Marius Möller, Hauke Busch, Inga Vater, Malte Spielmann, Ingolf Cascorbi, Inga Nagel

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 63%
Student > Ph. D. Student 1 13%
Student > Bachelor 1 13%
Unknown 1 13%
Readers by discipline Count As %
Unspecified 5 63%
Chemistry 1 13%
Medicine and Dentistry 1 13%
Unknown 1 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2023.
All research outputs
#17,327,859
of 26,215,093 outputs
Outputs from Frontiers in oncology
#6,886
of 22,936 outputs
Outputs of similar age
#213,188
of 390,760 outputs
Outputs of similar age from Frontiers in oncology
#230
of 1,096 outputs
Altmetric has tracked 26,215,093 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,936 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 390,760 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,096 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.